4.3 Review

Regulatory utility of physiologically-based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Biopharmaceutics Applications of Physiologically Based Pharmacokinetic Absorption Modeling and Simulation in Regulatory Submissions to the US Food and Drug Administration for New Drugs

Fang Wu et al.

Summary: The article summarizes the application of PBPK absorption modeling and simulation in drug product development, highlighting its significant role in establishing relationships between critical quality attributes. It also provides insights into future directions for the use of PBPK in drug product quality assessment based on analysis of NDA submissions.

AAPS JOURNAL (2021)

Review Pharmacology & Pharmacy

Scientific considerations to move towards biowaiver for biopharmaceutical classification system class III drugs: How modeling and simulation can help

Fang Wu et al.

Summary: The 2017 FDA Guidance and ICH recommendations set criteria for BCS-based biowaivers, but establishing IVIVC for dosage forms with BCS III drugs remains a challenge.

BIOPHARMACEUTICS & DRUG DISPOSITION (2021)

Article Chemistry, Multidisciplinary

The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers

Alan Parr et al.

PHARMACEUTICAL RESEARCH (2016)

Article Pharmacology & Pharmacy

Matching phosphate and maleate buffer systems for dissolution of weak acids: Equivalence in terms of buffer capacity of bulk solution or surface pH?

Rodrigo Cristofoletti et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)

Article Pharmacology & Pharmacy

Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development

A. R. Maharaj et al.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)